BioCentury
ARTICLE | Company News

Teva sales and marketing update

June 20, 2016 7:00 AM UTC

Teva recalled all “pharmacy-level” inventory of migraine drug Zecuity sumatriptan in the U.S. and suspended sales and marketing after receiving postmarketing reports of patient skin burns at the appl...